Back to search

Aristotle University Of Thessaloniki (AUTH)

Η επίδραση της bevacizumab στις ενδοκοιλιακές μετεγχειρητικές συμφύσεις: πειραματική μελέτη σε επίμυες

Abstract

dc:description

Postoperative peritoneal adhesions are among the most frequent and grave complications of abdominal surgery. They can cause bowel obstruction, chronic pelvic pain, infertility and difficulties in subsequent operations, by increasing operating times and risk of splanchnic injury. Their increased incidence and their consequences are the reasons for the continuous research for an efficient and safe antiadhesive agent. Up to now, a large number of different medicines and methods have been tested. In this study, we evaluated the efficacy of bevacizumab in the prevention of peritoneal postoperative adhesions. For this purpose, 90 Wistar Albino male rats were randomly allocated to three groups. Group one received bevacizumab (group BE), group two received normal saline (group P) and group three was the sham group. Each group was further divided into three subgroups, according to reoperation day. The subjects in group one underwent abrasion of the cecum wall with a dry gauze and intraperitoneal instillation of bevacizumab, at a dosage of 5mg/Kg. The subjects in group two underwent the same procedure and received intraperitoneal normal saline in the same dosage and the subjects in group three did not undergo any procedure. Reoperation was performed in postoperative days 2, 14 and 28. (Subgroups ΒΕ-2, ΒΕ-14, ΒΕ-28 και Ρ-2, Ρ-14, Ρ-28) At re-operation, two blinded to the study-groups surgeons clinically assessed the adhesions according to a predetermined scale. Tissue and blood samples for laboratory measurements of tissue plasminogen activator (tPA), plasminogen activator inhibitor -1(PAI-1) and metalloproteinase-9 (MMP-9) and for histopathological assessment were obtained. Adhesions were clinically less, in extent and severity in all the bevacizumab sub-groups. In addition, tPA concentrations in tissue samples were higher in all the study sub-groups. PAI-1 concentrations were significantly lower in peritoneum samples in subgroups BE-2 and BE-14 and in cecum samples in all the BE subgroups. MMP-9 concentrations were higher in tissue samples in all the BE subgroups and in blood samples of group BE-14 compared to P-14. Histopathological analysis demonstrated differences in fibrosis and angiogenesis in the subgroups of postoperative days 14 and 28.Our findings show that intraperitoneal instillation of a single therapeutic dose of bevacizumab can reduce postoperative peritoneal adhesions. This action seems to start in the early postoperative period and continues until the 28th postoperative day.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2017

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Micha, Aikaterini-Eftychia
  • Μίχα, Αικατερίνη-Ευτυχία

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/42206

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Micha, Aikaterini-Eftychia; Μίχα, Αικατερίνη-Ευτυχία. Η επίδραση της bevacizumab στις ενδοκοιλιακές μετεγχειρητικές συμφύσεις: πειραματική μελέτη σε επίμυες. Aristotle University Of Thessaloniki (AUTH), 2017. http://hdl.handle.net/10442/hedi/42206